MDNA logo

Medicenna Therapeutics (MDNA) Working Capital

Annual Working Capital

$24.09 M
+$7.45 M+44.80%

March 31, 2023


Summary


Performance

MDNA Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMDNAbalance sheetmetrics:

Quarterly Working Capital

$21.32 M
-$2.77 M-11.50%

June 30, 2023


Summary


Performance

MDNA Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMDNAbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

MDNA Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.8%+53.2%
3 y3 years-5.2%-25.8%
5 y5 years+1190.5%+1391.9%

MDNA Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-20.1%-30.9%-26.3%-34.7%
5 y5-year-20.1%-91.6%-29.3%-81.2%
alltimeall time-20.1%-97.5%-29.3%-99.0%

Medicenna Therapeutics Working Capital History

DateAnnualQuarterly
Jun 2023
-
$21.32 M(-11.5%)
Mar 2023
$24.09 M(+44.8%)
$24.09 M(-6.9%)
Dec 2022
-
$25.88 M(-10.5%)
Sep 2022
-
$28.93 M(+107.9%)
Jun 2022
-
$13.91 M(-16.4%)
Mar 2022
$16.64 M(-44.8%)
$16.64 M(-10.4%)
Dec 2021
-
$18.57 M(-3.6%)
Sep 2021
-
$19.27 M(-26.0%)
Jun 2021
-
$26.04 M(-13.6%)
Mar 2021
$30.14 M(+18.6%)
$30.14 M(+13.0%)
Dec 2020
-
$26.66 M(-0.5%)
Sep 2020
-
$26.80 M(-6.8%)
Jun 2020
-
$28.75 M(+13.1%)
Mar 2020
$25.41 M
$25.41 M(+532.9%)
Dec 2019
-
$4.02 M(+1746.1%)
Sep 2019
-
$217.50 K(-84.7%)
DateAnnualQuarterly
Jun 2019
-
$1.42 M(-29.9%)
Mar 2019
$2.03 M(+8.7%)
$2.03 M(-23.2%)
Dec 2018
-
$2.64 M(+158.9%)
Sep 2018
-
$1.02 M(-28.6%)
Jun 2018
-
$1.43 M(-23.5%)
Mar 2018
$1.87 M(-64.6%)
$1.87 M(-7.3%)
Dec 2017
-
$2.01 M(-36.8%)
Sep 2017
-
$3.19 M(-21.1%)
Jun 2017
-
$4.04 M(-23.4%)
Mar 2017
$5.28 M(+219.1%)
$5.28 M(+49.6%)
Dec 2016
-
$3.53 M(+489.9%)
Sep 2016
-
$597.80 K(-3.7%)
Jun 2016
-
$620.60 K(-1.0%)
Mar 2016
$1.65 M(+176.7%)
$626.70 K(-2.2%)
Dec 2015
$597.50 K
-
Sep 2015
-
$640.50 K(+63.9%)
Jun 2015
-
$390.90 K

FAQ

  • What is Medicenna Therapeutics annual working capital?
  • What is the all time high annual working capital for Medicenna Therapeutics?
  • What is Medicenna Therapeutics annual working capital year-on-year change?
  • What is Medicenna Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Medicenna Therapeutics?
  • What is Medicenna Therapeutics quarterly working capital year-on-year change?

What is Medicenna Therapeutics annual working capital?

The current annual working capital of MDNA is $24.09 M

What is the all time high annual working capital for Medicenna Therapeutics?

Medicenna Therapeutics all-time high annual working capital is $30.14 M

What is Medicenna Therapeutics annual working capital year-on-year change?

Over the past year, MDNA annual working capital has changed by +$7.45 M (+44.80%)

What is Medicenna Therapeutics quarterly working capital?

The current quarterly working capital of MDNA is $21.32 M

What is the all time high quarterly working capital for Medicenna Therapeutics?

Medicenna Therapeutics all-time high quarterly working capital is $30.14 M

What is Medicenna Therapeutics quarterly working capital year-on-year change?

Over the past year, MDNA quarterly working capital has changed by +$7.41 M (+53.23%)